Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study

MLA

Brendon Stubbs, et al. “Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study.” Drugs & Aging, vol. 36, Feb. 2019, pp. 387–93. EBSCOhost, https://doi.org/10.1007/s40266-019-00642-3.

APA

Brendon Stubbs, Stefania Maggi, Jacopo Demurtas, Sarah E Jackson, Pinar Soysal, Nicola Veronese, Ai Koyanagi, Lee Smith, & Stefano Celotto. (2019). Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study. Drugs & Aging, 36, 387–393. https://doi.org/10.1007/s40266-019-00642-3

Chicago

Brendon Stubbs, Stefania Maggi, Jacopo Demurtas, Sarah E Jackson, Pinar Soysal, Nicola Veronese, Ai Koyanagi, Lee Smith, and Stefano Celotto. 2019. “Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study.” Drugs & Aging 36 (February): 387–93. doi:10.1007/s40266-019-00642-3.